The expression and regulation of microRNA-125b in cancers

Ke Huang1, Shiwu Dong, Wei Li

  • 1National & Regional United Engineering Laboratory of Tissue Engineering, Department of Orthopaedics, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.

Insights

MicroRNA-125b (miR-125b) shows promise as a diagnostic biomarker for various cancers. This review explores its role in cancer development and its potential as a therapeutic target for neoplastic diseases.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer remains a leading global cause of mortality, necessitating innovative diagnostic and therapeutic strategies.
  • Altered gene expression, particularly microRNAs, is implicated in carcinoma development.
  • MicroRNA-125b (miR-125b) is a key regulator of diverse biological processes.

Purpose of the Study:

  • To review the current understanding of the link between cancer-related miR-125b and various malignancies.
  • To discuss the functional roles of miR-125b in disease processes, including cancer.
  • To evaluate miR-125b's potential as a diagnostic biomarker and therapeutic target.

Main Methods:

  • Literature review of recent studies on miR-125b and cancer.
  • Analysis of miR-125b's involvement in cellular processes relevant to malignancy.
  • Identification and validation of miR-125b as a cancer biomarker.

Main Results:

  • miR-125b expression is altered in several cancer types.
  • miR-125b regulates critical cellular functions such as proliferation, differentiation, and apoptosis.
  • Evidence supports miR-125b's utility as a diagnostic biomarker.

Conclusions:

  • miR-125b is a significant factor in cancer pathology.
  • miR-125b holds potential as a reliable biomarker for cancer diagnosis.
  • Targeting miR-125b offers a promising therapeutic avenue for neoplastic diseases.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...